E2F1 identified by promoter and biochemi
✍
Roy Blum; Itay Nakdimon; Liat Goldberg; Ran Elkon; Ron Shamir; Gideon Rechavi; Y
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
French
⚖ 690 KB
## Abstract Active Ras contributes to the malignant phenotype of glioblastoma multiforme. Recent studies showed that the Ras inhibitor farnesyl thiosalicylic acid downregulates the transcription factor hypoxia‐inducible factor‐1α, causing shutdown of glycolysis in U87 glioblastoma cells. Farnesyl t